ArticleCancers2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
David Zahrieh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.